Frontlight ResearchEarly access
Trial site
Kayseri
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria3 trials
- IgA nephropathy3 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Hidradenitis suppurativa1 trial
- Lupus (SLE)1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- and 2 more
- Phase
- Phase 39 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Closed trials
Completed
Terminated
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026